SASS-001
- Generic Name
- SASS-001
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Phase 2
Recruiting
- Conditions
- Sleep Apnea
- Interventions
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- Shionogi Apnimed Sleep Science
- Target Recruit Count
- 60
- Registration Number
- NCT06776432
- Locations
- 🇺🇸
Teradan Clinical Trials, Brandon, Florida, United States
🇺🇸PharmaDev Clinical Research Institute, LLC, Miami, Florida, United States
🇺🇸Intrepid Research, LLC, Cincinnati, Ohio, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath